Skip to main content
BNC Korea Co, Ltd logo

BNC Korea Co, Ltd — Investor Relations & Filings

Ticker · 256840 ISIN · KR7256840000 KO Manufacturing
Open in API
Filings indexed 283 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 256840

About BNC Korea Co, Ltd

http://www.bnckorea.co.kr

BNC Korea Co., Ltd. is a biomedical company established in 2007 that engages in the research, development, production, and sale of medical devices, pharmaceuticals, and biologicals. The company specializes in products derived from biomaterials, with a particular focus on hyaluronic acid. Its core product portfolio includes hyaluronic acid-based dermal fillers and botulinum toxin injectables for the medical aesthetics market. BNC Korea operates a GMP-certified facility for manufacturing cutting-edge drug substances and specialty medicines, aiming to develop strategic application products for next-generation bio markets.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) covering the period January 1, 2026 to March 31, 2026. It contains comprehensive interim financial data, company overviews, business segment details, and statutory disclosures typical of a full quarterly filing rather than a brief earnings release or announcement. Therefore it is an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
소속부변경
Regulatory Filings
2026-04-30 Korean
기타시장안내(약명및영문명)
Regulatory Filings Classification · 80% confidence The document is a short announcement (278 characters) regarding changes to the company’s stock item name and English name for listing purposes. It is not a financial report itself or any detailed report, but a regulatory notice of a non-financial change. There is no specific category for name/ticker changes, so it falls under the fallback “Regulatory Filings” category.
2026-04-27 Korean
[기재정정]사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 10th fiscal year (2025), which is the Korean equivalent of a 10-K annual report. It contains detailed financial data, business descriptions, management discussions, and corporate governance information. Although it is labeled as a 'correction' (정정신고), it is a full-scale annual report filing, not a mere announcement of a report. FY 2025
2026-04-08 Korean
상호변경안내
Regulatory Filings Classification · 91% confidence The document is a formal notice of a corporate name change (“상호변경안내”) with details of the old and new names, date of the shareholders’ meeting, and rationale. It does not present financial results, board appointments, or any financing or legal details, nor is it an AGM presentation or financial report. It is a straightforward regulatory announcement of a corporate action for which no specific category exists, so it falls under the fallback “Regulatory Filings.”
2026-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is titled “정기주주총회 결과” (regular shareholders’ meeting results) and provides detailed voting outcomes for each agenda item, including approval of financial statements, dividend resolutions, board and auditor elections, and vote percentages. This matches the Definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-03-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.